Promoter holding
64.27%
SB
Solitaire Biotech Pvt Ltd - Due diligence report
A 360° intelligence report on Solitaire Biotech Pvt Ltd: trust score, financial health, credit view, compliance, directors, growth and distr…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Solitaire Biotech Pvt Ltd — 360° Intelligence Report
Generated from MCA filings & public records70/100
Trust Score
Moderate
Solitaire Biotech Pvt Ltd is assessed as Moderate with a Trust Score of 70/100. Solitaire Biotech Pvt Ltd is an active private limited indian non-government company incorporated in 2006, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 25 Jul 2026 from the latest processed filings. Solitaire Biotech Pvt Ltd snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
80/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
40/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
45/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 40/100 Caution Indicated
- Liabilities ≈ 38% EBITDA - stretched.
- Elevated gearing (D/E 1.42).
- Profitable - internal accruals available.
Charges position: 1 open (10.00 Lakh) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Canara Bank | 1 | 48.0 cr |
Compliance Score: 80/100 Low Risk
- Company status is Active as per MCA.
- Marked ACTIVE non-compliant (INC-22A).
- Annual filings current (balance sheet Mar 2025).
- 1 active GST registration(s).
05
Director Intelligence
Stability score: 45/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| ARUN KUMAR GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SAVITRI GUPTA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 2 directors on the board.
- SAVITRI GUPTA has DIN status "Deactivated due to non-filing of DIR-3 KYC".
- 1 director exit(s) in the last 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 50 · Distress 75
Growth signals & trust indicators
Operating for 20+ years.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
1 open charge(s) registered - assets are encumbered.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment54/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 10.00 Lakh already registered.
- Compliance record supports lending.
Investor view57/100
Mixed indicators
Growth quality and scalability through an investor lens.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 7 events30 Sep 2025
Last AGM held
Annual general meeting
19 Jul 2025
Charge created
Canara Bank - 10.00 Lakh
31 Mar 2025
Latest balance sheet
Filed with ROC
03 Feb 2024
Director ceased
DHARAM PAUL GUPTA
08 Mar 2006
Incorporated
Registered with Roc Chandigarh
Director appointed
ARUN KUMAR GUPTA (Director)
Director appointed
SAVITRI GUPTA (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
| Company | CIN | Location |
|---|---|---|
| Eastern Textiles Pvt Ltd | U17299WB1994PTC065646 | Kolkata, West Bengal, India |
| Madonis Vyapar Pvt.Ltd. | U51395WB1994PTC066028 | Kolkata, West Bengal, India |
| Nimai Finance Private Limited | U74899DL1993PTC052976 | New Delhi, Delhi, India |
| Grip Rehabilitation Private Limited | U51909CH2010PTC031992 | Chandigarh, Chandigarh, India |
| Bayonet Pharmaceuticals | U24100TN2014PTC095154 | Ambattur, Tamil Nadu, India |
| Pv Well Being Private Limited | U15400WB2022PTC252186 | Kolkata, West Bengal, India |
| Tele Tone India Pvt. Ltd. | U32205WB1992PTC054955 | Kolkata, West Bengal, India |
| Elza Laboratories India Private Limited | U74999CH2018PTC041914 | Chandigarh, Chandigarh, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Solitaire Biotech Pvt Ltd before audits and certifications: compliance score 80/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Solitaire Biotech Pvt Ltd: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Solitaire Biotech Pvt Ltd - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Solitaire Biotech Pvt Ltd pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Solitaire Biotech Pvt Ltd - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Solitaire Biotech Pvt Ltd an active company?
Solitaire Biotech Pvt Ltd has MCA status “Active” with a compliance score of 80/100 (Low Risk).
Is Solitaire Biotech Pvt Ltd financially healthy?
Solitaire Biotech Pvt Ltd has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.
Should I do business with Solitaire Biotech Pvt Ltd?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Solitaire Biotech Pvt Ltd?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.
Does Solitaire Biotech Pvt Ltd have loans or charges against its assets?
1 open charge(s) are registered against its assets.
Is Solitaire Biotech Pvt Ltd up to date with its ROC filings?
Marked ACTIVE non-compliant (INC-22A). Overall compliance score: 80/100 (Low Risk).
Is it risky to lend to Solitaire Biotech Pvt Ltd?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
